Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.
The Global Biosimulation market showcased growth at a CAGR of 16.05% during 2020-2023. The market was valued at USD 6.09 billion in 2023 which is expected to reach USD 14.57 billion in 2030. This report provides an analysis for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.
Biosimulation involves the use of computer-aided modeling and simulation techniques to predict the behaviour and outcomes of biological processes, drug interactions, and disease progression. It plays a critical role in drug discovery, development, and precision medicine by minimizing costs and reducing time-to-market for new therapies.
The growth of this Market is expected to be fuelled by ongoing technological advancements, increasing adoption across various sectors, and the expanding applications of Biosimulation in defence, industrial bioprocessing, nutraceuticals, and agri-food production.
The global ELISA diagnostics market is projected to grow significantly, with its adoption driven by the increasing burden of diseases such as HIV, hepatitis, and autoimmune conditions. The test's reliability, sensitivity, and adaptability to various sample types make it a preferred choice in clinical and research settings.
Americas holds the largest market share driven by advanced R&D infrastructure, strong pharmaceutical and biotechnology industries, and favourable regulatory support from agencies like the FDA. The United States dominates this region due to extensive investments in drug discovery and precision medicine.
Emerging markets in Asia-Pacific and the Middle East and Africa are witnessing accelerated growth, spurred by improved healthcare access and rising awareness of early disease detection.
Scope of the Report
- The report analyses the Biosimulation Market by Value (USD Million).
- The report analyses the Biosimulation Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
- The report presents the analysis of Biosimulation Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
- The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Application and By Deployment Model Outlook.
- Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.
Analyst Recommendations
- Advancements in Precision Oncology
- Integration with Digital Twins
Global Biosimulation Market: Historic and Forecast
Impact Analysis of Macro Economic Factors on Biosimulation Market
- Incorporation of Biosimulation in FDA guidance
- List of systems biology modeling software
- Global Biosimulation Market: Dashboard
- Global Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
- Global Biosimulation Market: Market Value Assessment
Global Biosimulation Market Segmentation: By Type
- Type Overview
- Global Biosimulation Market Attractiveness Index, By Type
- Services, By Value, 2020H-2030F (USD Million & CAGR)
- Software, By Value, 2020H-2030F (USD Million & CAGR)
Global Biosimulation Market Segmentation: By Application
- Application Overview
- Global Biosimulation Market Attractiveness Index, By Application
- Drug Development, By Value, 2020H-2030F (USD Million & CAGR)
- Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)
- Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
Global Biosimulation Market Segmentation: By Deployment Model Outlook
- Deployment Model Outlook Overview
- Global Biosimulation Market Attractiveness Index, By Deployment Model Outlook
- Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)
- On-premise, By Value, 2020H-2030F (USD Million & CAGR)
- Hybrid Model, By Value, 2020H-2030F (USD Million & CAGR)
Competitive Positioning
- Companies' Product Positioning
- Market Position Matrix
- Market Share Analysis of Biosimulation Market
Company Profiles
- Certara, Inc.
- Advanced Chemistry Development, Inc.
- Simulations Plus, Inc.
- Chemical Computing Group
- Dassault Systemes Scientific
- Schrodinger, Inc.
- Genedata
- MathWorks
- Netabolics
- Cellworks
For more information about this report visit https://www.researchandmarkets.com/r/v8tad6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
